Education related to hepatitis C and HIV. International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries. Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Expanding access to HIV treatment and prevention therapies including, Administration proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Pharmaceutical policy as it relates to payments under the 340B program. 

H.R.3 - Lower Drug Costs Now Act of 2019
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S.3013 - Encouraging Innovate Benefit Design to Lower Costs for Seniors Act 
H.R.1643 - PrEP Assistance Program Act
S.1926 - The PrEP Access and Coverage Act Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including the New Technology Add-On Payment program. Part D benefit redesign. Administration regulations including: "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of Pocket Spending"; "Medicare Program; Hospital Inpatient Prospective Payment Systems for Fiscal Year 2020 Rates; Proposed Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Proposed Requirements for Eligible Hospitals and Critical Access Hospitals" (84 FR 19158, 42 CFR 412). 

S.2543 - The Prescription Drug Pricing Reduction Act of 2019
S.3129 - Lower Costs, More Cures Act of 2019 
H.R.3 - Lower Drug Costs Now Act of 2019 
H.R.19 - Lower Costs, More Cures Act of 2019
H.R.259 - Medicaid Extenders Act of 2019 Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations. 

H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
H.R. 1865 - Further Consolidated Appropriations Act, 2020
H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
VET - Veterans TRD - Trade (domestic/foreign) CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404, US
DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI DAVID PULLIAM CHARLES M. CLAPTON DAVID PULLIAM CHARLES M. CLAPTON DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI MICHAEL D BOYD DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI MICHAEL D BOYD DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI